Studies at DuPont suggest clinical utility of SF-303 and SK-549 as novel antithrombotics Jan. 28, 2000
EPISTENT diabetic subgroup results: abciximab + stenting associated with better outcome Jan. 26, 2000
Antiplatelet agent OPC-29030 appears to act by inhibiting 12-lipoxygenase translocation Jan. 19, 2000
RSS